Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery [NA]
This clinical trial aims to evaluate high-volume washing of the abdomen during surgery to improve survival in patients with resectable pancr…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer [Phase 1]
A Phase 1 study of armed, activated T-cells for advanced pancreatic cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Predicting Effective Therapy in Pancreatic Cancer
A Memorial Sloan Kettering Cancer Center-led clinical trial aiming to predict effective therapies for pancreatic cancer is currently active …
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Activation of Biobank Registry for Bilio-pancreatic Diseases
A biobank registry for biliopancreatic diseases has been activated and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) [Phase 1]
Phase 1 clinical trial SHAPER investigates losartan with hypofractionated radiotherapy after chemotherapy for Borderline Resectable or Local…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: 68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma [NA]
Clinical trial update describing the imaging agent 68Ga-FAPI-46 for staging pancreatic adenocarcinoma, with the study not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma
This clinical trial update describes a study investigating the impact of perioperative nutritional status and its management on outcomes in …
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
This clinical trial update describes a study on prognostic and predictive markers of treatment response in patients with pancreatic adenocar…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating sotorasib in combination with first-line chemotherapy for advanced pancreatic adenocarcinoma; the stu…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Biological and Clinical Database for Pancreatic Adenocarcinoma
A clinical trial update for a biological and clinical database in pancreatic adenocarcinoma; the study is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: SERum-bank for PANcreatic Cancer
This entry describes a serum-bank study for pancreatic cancer that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and cisplatin with or without veliparib, or veliparib alone, in locally advanced…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP ) [NA]
A clinical trial update describes a pilot study combining EUS-guided radiofrequency ablation with FOLFIRINOX for advanced pancreatic cancer,…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
An ongoing clinical trial sponsored by Carol Davila University of Medicine and Pharmacy is assessing the prevalence of pancreatic steatosis …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
This is a clinical trial update describing the LINFU U.S. Registry for patients with intraductal papillary mucinous neoplasm (IPMN) of the p…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 to standard chemotherapy for advanced solid tumors, focusing on small cell lung cancer, poorly d…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study of LP-184 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Lantern Pharma's LP-184 is being studied in a phase 1/2 trial for advanced and metastatic solid tumors, with indications including glioblast…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating a personalized vaccine in combination with standard-of-care chemotherapy followed by nivolumab in pancreatic adenoc…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial [Phase 2]
A randomized phase II trial evaluating perioperative NALIRIFOX (liposomal irinotecan in combination with fluorouracil, leucovorin, and oxali…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC [Phase 2]
Phase 2 trial evaluating QL1706 with AG chemotherapy as first-line treatment for advanced pancreatic adenocarcinoma. The study is not yet re…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
This clinical trial update describes the PARA study on risk factors for exocrine pancreatic neoplasms, focusing on pancreatic adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]
Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
This clinical trial update from Charles University investigates whether secretin-stimulated pancreatic secretion affects ctDNA expression in…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Namodenoson Treatment of Advanced Pancreatic Cancer [Phase 2]
Clinical trial update for Namodenoson in advanced pancreatic cancer (pancreatic adenocarcinoma). The Phase 2 study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update investigating first-line treatment of advanced pancreatic cancer with albumin-bound paclitaxel and gemcitabine, with or…